Dr. Évelyne Vinet (MD, PhD) is an Associate Professor in the Division of Rheumatology at McGill University. She is also a Medical Scientist for the Centre for Health Outcomes Research at the Research Institute of the McGill University Health Centre (MUHC), an associate member of the McGill Department of Epidemiology, Biostatistics and Occupational Health and a full member of the McGill Division of Experimental Medicine. Dr. Vinet is an attending staff at the MUHC Lupus & Vasculitis clinic and she leads the MUHC Rheumatology & Reproduction clinic. The primary goal of Dr. Vinet’s research program is to use epidemiologic methods to improve reproductive health outcomes in women with rheumatic diseases, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and their offspring. To this end, Dr. Vinet has created the world's largest cohort of offspring from SLE women, which has driven their novel findings demonstrating that SLE offspring are at increased risk of autism spectrum disorders, congenital heart defects, and stillbirths. Dr. Vinet is also actively spear-heading research initiatives to elucidate how therapies used to treat rheumatic diseases (e.g. TNF-inhibitors and other biologics) impact health outcomes in these patients and their offspring. Dr. Vinet has been an active committee member of the 2020 American College of Rheumatology guidelines on reproductive health in rheumatic diseases. Finally, Dr. Vinet is leading an international multi-centre prospective cohort study of lupus pregnancies, the “Lupus in prEGnACY (LEGACY)” cohort, to allow early risk stratification and personalized therapy of pregnancies.